Wayne State University, Institute of Gerontology, Department of Family Medicine and Public Health Sciences, 87 East Ferry Street, 226 Knapp Building, Detroit, MI 48202, USA.
J Psychiatr Res. 2012 Apr;46(4):456-61. doi: 10.1016/j.jpsychires.2012.01.011. Epub 2012 Jan 25.
To examine and describe vascular depression epidemiology in the United States.
Cross-sectional data from a national probability sample of household resident adults (18-years and older; N = 16,423) living in the 48 coterminous United States were analyzed to calculate prevalence estimates of vascular depression, associated disability and treatment rates. In this study, vascular depression was defined as the presence of cardiovascular and cerebrovascular disease (CVD) and CVD major risk factors (e.g., diabetes, hypertension, heart disease, and obesity) among adults 50-years and older who also met 12-month DSM-IV major depression criteria.
We estimated that about 3.4% or approximately 2.64 million American adults 50-years and older met our criteria for vascular depression. Among adults who met criteria for lifetime major depression, over one-in-five (22.1%) were considered to have the vascular depression subtype. Secondly, vascular depression was associated with significantly increased functional impairment relative to the non-depressed population and adults meeting criteria for major depression alone. Although depression care use was significantly higher among vascular depression respondents relative to those with major depression alone, practice guideline concordant therapy use was not.
Vascular depression appears to be an important public health problem that affects a large portion of the U.S. adult population with major depression, and that it is associated with excess functional impairment without concomitant better depression care.
探讨并描述美国血管性抑郁症的流行病学特征。
本研究采用全国概率抽样的方法,对居住在美国 48 个州的 18 岁及以上的常住居民(n=16423)进行横断面数据分析,以计算血管性抑郁症的患病率、相关残疾率和治疗率。在本研究中,血管性抑郁症定义为 50 岁及以上的成年人同时患有心血管疾病和脑血管疾病(CVD)以及 CVD 主要危险因素(如糖尿病、高血压、心脏病和肥胖症),并符合 12 个月 DSM-IV 重性抑郁障碍标准。
我们估计约有 3.4%或约 264 万美国 50 岁及以上的成年人符合我们的血管性抑郁症标准。在符合终生重性抑郁障碍标准的成年人中,超过五分之一(22.1%)被认为属于血管性抑郁症亚型。其次,与非抑郁人群和仅符合重性抑郁症标准的成年人相比,血管性抑郁症与明显更高的功能损害相关。尽管血管性抑郁症患者的抑郁治疗使用率明显高于仅患有重性抑郁症的患者,但与实践指南一致的治疗使用率并没有提高。
血管性抑郁症似乎是一个重要的公共卫生问题,影响了美国大部分患有重性抑郁症的成年人,且与功能损害增加有关,但同时并未提高抑郁治疗效果。